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Abstract
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Traumatic brain injury (TBI) is a major cause of death and disability. However, the molecular
events contributing to the pathogenesis are not well understood. Mitochondria serve as the
powerhouse of cells, respond to cellular demands and stressors, and play an essential role in cell
signaling, differentiation, and survival. There is clear evidence of compromised mitochondrial
function following TBI, however, the underlying mechanisms and consequences are not clear.
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression posttranscriptionally, and function as important mediators of neuronal development, synaptic
plasticity, and neurodegeneration. Several miRNAs show altered expression following TBI,
however, the relevance of mitochondria in these pathways is unknown. Here, we present evidence
supporting the association of miRNA with hippocampal mitochondria, as well as changes in
mitochondria-associated miRNA expression following a controlled cortical impact (CCI) injury in
rats. Specifically, we found that the miRNA processing proteins Argonaute (AGO) and Dicer are
present in mitochondria fractions from uninjured rat hippocampus, and immunoprecipitation of
AGO associated miRNA from mitochondria suggests the presence of functional RNA-induced
silencing complexes. Interestingly, RT-qPCR miRNA array studies revealed that a subset of
miRNA is enriched in mitochondria relative to cytoplasm. At 12 hour following CCI, several
miRNAs are significantly altered in hippocampal mitochondria and cytoplasm. In addition, levels
of miR-155 and miR-223, both of which play a role in inflammatory processes, are significantly
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elevated in both cytoplasm and mitochondria. We propose that mitochondria-associated miRNAs
may play an important role in regulating the response to TBI.

Keywords
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inflammation; miR-142-3p; miR-142-5p; miR-146a; miR-155; miR-223; miR-150

Introduction
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Traumatic brain injury (TBI) is a major cause of death and disability affecting an estimated
1.7 million people annually in the United States alone (Faul M, 2010). The personal and
health consequences associated with TBI are substantial with an estimated annual financial
burden of over $75 billion in direct medical costs and other indirect costs (Finkelstein et al.,
2006). At the present time, no effective treatment exists due, in part, to the widespread
impact of numerous complex secondary biochemical and pathophysiological events
occurring at different time points following the initial injury (McIntosh et al., 1998;
Rosenfeld et al., 2012). These secondary injury events include, but are not limited to edema,
excitotoxicity, inflammation, oxidative stress/damage, activation of necrotic and apoptotic
cell death-signaling events, and impaired mitochondrial function (Rink et al., 1995; Clark et
al., 2000; Sullivan et al., 2002; Lifshitz et al., 2004; Raghupathi, 2004; Singh et al., 2006;
Ziebell and Morganti-Kossmann, 2010). Mitochondria play an essential role in maintaining
cellular homeostasis by responding to cellular energy demands and participating directly in a
wide range of cellular events including cell signaling, metabolism, and survival, in addition
to cell death pathways (Saraste, 1999; McBride et al., 2006). Importantly, it has been well
documented that the degree of mitochondrial dysfunction and recovery following TBI is a
critical determinant of subsequent cell survival or death (Sullivan et al., 2002; Lifshitz et al.,
2003; Lifshitz et al., 2004; Singh et al., 2006; Pandya et al., 2009; Patel et al., 2009). These
vital roles for mitochondria in cellular function and survival have resulted in increased
efforts to identify the molecular events associated with mitochondrial impairment in TBI.

Author Manuscript

Mitochondria respond rapidly to a wide range of stressors and cellular requirements. Several
studies have documented the localization of microRNA (miRNA) processing machinery and
various miRNA in mitochondrial fractions isolated from a variety of cells and tissues (Lung
et al., 2006; Kren et al., 2009; Bian et al., 2010; Bandiera et al., 2011; Barrey et al., 2011;
Huang et al., 2011; Mercer et al., 2011; Das et al., 2012; Hu et al., 2012; Sripada et al.,
2012). MiRNAs are short, non-coding RNA molecules that bind to recognition elements in
mRNA and regulate gene expression post-transcriptionally either by mRNA degradation or
translational repression (Bartel, 2004; Chen and Rajewsky, 2007; Bartel, 2009; Huntzinger
and Izaurralde, 2011). Disruption of miRNA function contributes to many disease states
including cancer, cardiovascular disease, and neurodegeneration (Calin and Croce, 2006;
Nelson et al., 2008a; Hata, 2013). The biological actions of miRNA are thought to require
the cytoplasmic processing by Dicer, interaction with Argonaute (AGO) proteins and
assembly into RNA-induced silencing complexes (RISC) (Liu et al., 2008; Bartel, 2009),
which promotes and stabilizes miRNA base pair annealing with target mRNA. Recently,
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mitochondria have been shown to interact with AGO-miRNA containing processing bodies
(P-bodies), and that mild uncoupling of mitochondria decreases cellular miRNA functional
efficiency (Huang et al., 2011). The ability of a single miRNA or miRNA family to regulate
the post-transcriptional expression of hundreds of genes makes them ideal candidates for
coordinating complex gene expression programs, including modifying a cell’s response to
stressors or mounting a protective or pathological response following TBI. Recent
experimental studies have reported altered expression levels of several miRNAs in both
cortex and hippocampus following controlled cortical impact (CCI), fluid percussion injury,
and contusive spinal cord injury (Lei et al., 2009; Liu et al., 2009; Redell et al., 2009; Redell
et al., 2010; Strickland et al., 2011; Truettner et al., 2011; Hu et al., 2012; Yunta et al., 2012;
Hu et al., 2013; Truettner et al., 2013; Di et al., 2014; Liu et al., 2014; Sabirzhanov et al.,
2014; Sun et al., 2014). However, the signaling events regulating cellular miRNA activity
and/or function in response to TBI are largely unknown.
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In the present study, we demonstrate the presence of miRNA protein machinery in
mitochondrial fractions of rat hippocampal tissue. In addition, miRNAs were found in AGOcontaining complexes co-immunoprecipitated from purified mitochondria supporting a role
for mitochondria in regulating miRNA activity. Importantly, a subset of miRNAs was
preferentially enriched in hippocampal mitochondria preparations under normal conditions,
and several miRNAs were found to decrease following a severe TBI. These studies point
towards a novel role for mitochondrial regulation of miRNA expression in response to TBI.

Materials and Methods
Surgical procedures for traumatic brain injury
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All procedures and protocols were approved by the University of Kentucky Institutional
Animal Care and Use Committee. Young adult male Sprague–Dawley rats weighed 250–
300 g (Harlen Laboratories, IN) were housed for 7 days prior to experimentation to allow
them to acclimate to the environment. All animals were maintained in a temperaturecontrolled vivarium room with free access to food and water. The surgical and controlled
cortical impact (CCI) injury procedures have been described in detail previously (Sullivan et
al., 1999). Briefly, animals were anesthetized with isoflurane (4%) and placed in a
stereotaxic frame (David Kopf, Tujunga, CA) prior to brain surgery. Isoflurane (2.5%) was
delivered via a nose cone throughout the surgical procedure. Using sterile procedures, the
skin was retracted and a 6-mm craniotomy was made lateral to the sagittal suture and
centered between bregma and lambda. The skull-cap was carefully removed without
disruption of the underlying dura. The exposed brain was then injured using a pneumatically
controlled impacting device consisting of a 5 mm diameter rod tip that compressed the
cortex at 3.5 m/s velocity to a depth of 2.0 mm. The use of these injury parameters results in
a severe injury to the cortex overlying the hippocampal formation (Baldwin et al., 1997;
Davis et al., 2008; Gilmer et al., 2009). Following CCI, the Surgicel (Johnson and Johnson)
was laid over the dura and the skull-cap was replaced. A thin coat of dental acrylica was
then spread over the craniotomy site and allowed it to dry before closing the overlying skin
with surgical staples. The core body temperatures of the animals were maintained at 37 °C
throughout the surgical procedures and recovery period.
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At 12 hr post-injury, animals were euthanatized with CO2 and the hippocampus from both
the injured and naïve animals (n=5 animals per group) were rapidly removed. Any potential
effect of a unilateral CCI on miRNA changes in the contralateral hippocampus has not been
investigated. Therefore, the hippocampi from naïve, uninjured animals were used to obtain
control tissue.
Isolation of mitochondria

Author Manuscript

For studies examining miRNA expression, the nuclear (P1), cytosolic (S2) and purified total
mitochondria (MT) fractions were isolated from rat hippocampus according to a previously
published ficoll density gradient procedure (Pandya et al., 2009). Briefly, tissue
homogenates were prepared in ice-cold mitochondrial isolation buffer (215 mM mannitol,
75 mM sucrose, 0.1% bovine serum albumin (BSA), 20 mM HEPES, 1 mM EGTA; pH
adjusted to 7.2 with KOH), followed by centrifugation two times at 1,300 g for 3 min to
obtain P1. The resulting supernatant was centrifuged at 13,000 g for 10 min to obtain crude
mitochondrial pellets (P2) and the supernatant was saved as S2. The P2 pellets were resuspended in isolation buffer and placed in a nitrogen cell disruption chamber (1200 psi, 10
min, at 4 °C) to rupture and release synaptosomal mitochondria (Brown et al., 2004). This
fraction was further purified using a discontinuous ficoll gradient (7.5% layered over 10%
ficoll) and centrifugation at 100,000 g (in SW 55Ti rotors) at 4 °C for 30 min. The resulting
MT pellet was washed and centrifuged at 10,000 g at 4 °C for 10 min in mitochondrial
isolation buffer without EGTA and finally resuspended to achieve a concentration of ~10
mg/ml in mitochondrial isolation buffer without EGTA for the miRNA expression studies.
The protein content of the above listed fractions was analyzed using BCA protein assay kit.
Isolation of mitochondrial sub-fractions from ficoll-purified mitochondria
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A mitochondria (MT) fraction was obtained from adult naïve rat brain as described above,
and further processed to generate mitochondrial sub-fractions according to a previously
published method (Atorino et al., 2003) with slight modifications. Briefly, 5 mg of MT was
subjected to hypotonic swelling in 1.5 ml of 5 mM HEPES/KOH, pH 7.4 for 20 min on ice
to rupture the outer mitochondrial membrane. The solution was then centrifuged at 1900 g at
4 °C for 15 min to obtain a mitoplast pellet (MP) and mitochondrial supernatant (MS)
containing broken outer mitochondrial membrane and inter-membrane space (IMS)
compartments. The MS fraction was then sonicated (10 seconds X 3 times) and centrifuged
35,000 g (utilizing SW 55Ti rotors) further at 4 °C for 15 min to pellet down the outer
membrane (OM), with the resulting supernatant containing only the inter-membrane space
(IMS) of mitochondria. The dense MP pellets were re-suspended in 250 μl of ice-cold
isolation buffer, sonicated (10 seconds X 3 times) and further centrifuged at 100,000 g
(utilizing SW 55Ti rotors) at 4 °C for 30 min. The resultant membrane-enriched pellet
contained the mitochondrial inner membrane (IM) and the resulting supernatant contained
the mitochondrial matrix (MTX) fractions. The protein content of the mitochondrial subfractions was determined using BCA protein assay.
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The purity of the mitochondria samples as well as identification of miRNA machinery
proteins in the sub-mitochondrial fractions were analyzed using standard Western blotting
techniques. Briefly, a total of 15 μg of protein was resolved according to molecular weight
by SDS–PAGE using either Criterion 4–20% Tris–HCl (10–250 kD) or Criterion 3–8% Triacetate (25–250 kD) gels (Bio-Rad, Hercules, CA). The gels were transblotted onto
polyvinylidene difluoride membranes, blocked with 5% nonfat dry milk for an hour, and
then incubated at 4 °C overnight with the primary antibody of interest. The primary
antibodies used included anti-Dicer mAb (1:500 dilution; cat # sc-136979; Santa Cruz
Biotechnology, Inc.), anti-Histone 3 rabbit mAb (H3; 1:25,000 dilution; cat # 4499; Cell
Signaling Technology Inc.), anti-pyruvate dehydrogenase rabbit mAb (PDH; 1:10,000
dilution; cat # 3205; Cell Signaling Technology Inc.), anti-voltage-dependent anion channel
rabbit polyAb (VDAC; 1:10,000 dilution; cat # PA1-954A; Thermo Scientific Inc.), anticomplex IV mAb (CoxIV; 1:200,000 dilution; Cat # A21348; Life Technologies Inc.), antibeta tubulin rabbit polyAb (1:100,000 dilution; cat # ab6046; Abcam Inc.), anti-beta actin
mAb (1:75,000 dilution; cat # A5316; Sigma-Aldrich), anti-CD45 rabbit polyAb (1:2,000
dilution; cat # ab10558; Abcam Inc.), anti-iNOS (1:10,000 dilution; cat # 610332; BD
Transduction Laboratories), and anti-Argonaute 2 mAb (2A8; 1:1000 dilution). The 2A8
Ago2 antibody has been described previously (Nelson et al., 2007). Peroxidase-conjugated
affinipure secondary antibodies included goat anti-mouse IgG and goat anti-rabbit IgG (cat #
115-035-166 and 111-035-144, respectively; Jackson ImmunoResearch laboratories, Inc.).
Primary rat brain cell culture

Author Manuscript

Primary cortical neuronal, astrocyte and microglial cultures were generated from Sprague–
Dawley rat pups at E18 as described previously (Wang et al., 2014).
RNA isolation from mitochondria and cytosol

Author Manuscript

Total RNA isolation using TRIZOL LS reagent (Life Technologies, USA) from cytosolic
fractions followed the modified procedure described previously (Nelson et al., 2008b; Wang
et al., 2008a). Total mitochondrial RNA isolation employed the same procedure with minor
modifications (double extraction) to accommodate RNA isolation from limited sample
quantity. Briefly, mitochondria were lysed in 250 μl RIPA buffer (10 mM Tris-Cl (pH 8.0),
1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS) in
the presence of protease inhibitors (Pierce, cat. # 78439) and RNasin (0.2 U/μl, Promega,
cat. # N2615). TRIZOL LS was then added to the mitochondria lysate. After chloroform
extraction and centrifugation, a 450-μl clear aqua-phase supernatant was saved. The
remaining 150–200 μl supernatant (which may contain some protein interface) was collected
separately, and was brought up to 250 μl using RIPA buffer. This supernatant was then
subjected to a second round of TRIZOL LS extraction following the same procedure. The
aqua-phase supernatants from both extractions were combined, and total RNA precipitated
using iso-propanol with glycogen (Roche, cat. # 10901393001) as carrier. Isolated RNA
concentrations were quantified using NanoDrop1000 Spectrophotometer (NanoDrop
Technologies, Inc.).
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Total RNA isolated from mitochondria and cytosol of each hippocampal tissue was
subjected to TaqMan® miRNA RT-qPCR array using Rodent Card A (Life Technologies).
Because of the relatively low levels of mitochondrial RNA and the benefit of uniformity, a
preamplification step using Megaplex™ PreAmp Primers (Life Technologies) was carried
out to enhance the detection ability for low-expression miRNAs. TaqMan® miRNA RTqPCR array was performed as described previously (Wang et al., 2014). Briefly, equal
amount of total RNA (50 ng) was reverse transcribed using the TaqMan® MicroRNA
Reverse Transcription Kit with Megaplex™ Primer Pools, Rodent Pool A (Life
Technologies). The resulting cDNA was pre-amplified using Megaplex™ PreAmp Primers,
Rodent Pool A (Life Technologies) before performing RT-qPCR Array. PCR was carried
out on the ViiA™ 7 Real-Time PCR System and qPCR cycle threshold (Ct) raw data
processed with ViiA 7 RUO software (Life Technologies).

Author Manuscript

TaqMan® single-tube miRNA RT-qPCR
Individual miRNA was subjected to single-tube TaqMan® assay (Life Technologies)
according to manufacturer’s instructions. TaqMan® assays were designed to follow MIQE
(Minimum Information for Publication of Quantitative Real-Time PCR Experiments)
guidelines (Bustin et al., 2009). An equal quantity (10–50 ng) of RNA was used in the
TaqMan® assays. All single-tube TaqMan® assays were performed without a preamplification except for the evaluation of miR-142-3p, miR-142-5p, and miR-146a, in
which the pre-amplification step was performed as in the array assays. A total of 3-5
biological replicates with 3 technical triplicates were performed for individual experiments.
Data analysis
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Raw PCR Ct values were first determined using ViiA 7 RUO software (Life Technologies)
with the same parameter settings across all samples (threshold set at 0.15 with automatic
baseline). Data corresponding to failed QC as determined by ViiA 7 RUO software were
excluded from the analysis. In addition, miRNAs with a PCR Ct value >35 were considered
as undetectable. DataAssist® software (Life Technologies) was then used to analyze
miRNA array data. Different array data from cytosol and mitochondria fractions were
normalized separately. The Global Mean Normalization method (Mestdagh et al., 2009) was
applied to normalize the pooled dataset of both Naïve and TBI. The Ct values presented in
this report, including the Supplemental data, are normalized data. The miRNA expression
levels between treatments (TBI vs Naïve) or mitochondria versus cytosol fractions from
naïve rat brain samples were expressed as fold changes using the following equation: fold
change=2^ −(CtTBI − CtNaive), or fold change=2^ −(CtMito − CtCyto), and were evaluated using
an unpaired Student t-test. Benjamini-Hochberg or permutation tests were used to control
False Discovery Rate (FDR), and all significant data points (p<0.05) had a FDR< 5%. The
data from the TaqMan® single-tube miRNA RT-qPCR assays were compared using
unpaired student t-tests with a p<0.05 considered as statistically significant.
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Results
Mitochondrial Purity
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To examine the purity (and contamination) of our preparations, total mitochondria (MT)
fractions were isolated from uninjured rat hippocampus and the proteins subjected to
immunoblotting to test for the presence of cytosolic and nuclear protein components. As
shown in Figure 1A, PDH, a mitochondrial matrix protein, was detected only in fractions
containing mitochondria. Neither β-tubulin, a cytosolic protein marker, nor the nuclear
protein marker, Histone H3, was detected in purified mitochondrial samples. The purity of
the mitochondria preparation was further examined using RT-qPCR for the presence of
cytosolic GAPDH mRNA (Figure 1B). Using this highly sensitive approach, GAPDH
mRNA levels were found to be ~50-fold lower in the mitochondria preparation compared to
the cytosolic fraction. Together, these experiments provide evidence that the mitochondria
preparation used in our experiments was relatively free of cytoplasmic and nuclear
contaminants.
Presence of AGO2-miRNA complexes in hippocampus mitochondria
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The localization of AGO and Dicer in mitochondrial fractions of naïve rat brain was
examined using immunoblotting with antibodies against AGO and Dicer. Western blot
analysis demonstrated that both miRNA machinery proteins were enriched in mitochondrial
matrix and outer membrane (Figure 2). The presence of miRNA machinery proteins in the
mitochondrial fractions prompted us to examine whether these fractions also contain AGOassociated miRNA complexes. The anti-AGO antibody 2A8 (Nelson et al., 2007) was used
to co-immunoprecipitate (co-IP) AGO protein complexes (Wang et al., 2010) from isolated
rat hippocampus mitochondrial (Mito-IP2A8) and cytosolic (Cyto-IP2A8) fractions.
Western blot analysis of the IP products showed that the anti-AGO antibody 2A8 (IP2A8),
but not normal mouse serum (IPNMS), effectively immunoprecipitated AGO2 from both the
cytosolic and mitochondrial fractions (Figure 3 inset). Total RNA was extracted from the
co-IP complexes and subjected to miRNA RT-qPCR TaqMan® assays for miR-124a and
miR-107, two brain-enriched miRNAs (Wang et al., 2014), and miR-23a, which has been
reported to be present in mitochondria (Das et al., 2012), as well as the small nuclear RNA
U6. The RT-qPCR results demonstrated that these test miRNAs, but not U6, were coimmunoprecipitated with and enriched in mitochondrial AGO complexes (Fig. 3). As
expected, IP using normal mouse serum (IPNMS, data not shown) in the same preparation
did not result in appreciable levels of these miRNAs.
Profiling of naïve hippocampal cytosolic and mitochondrial miRNAs

Author Manuscript

The TaqMan® RT-qPCR Array Rodent MicroRNA Card A (V2.0) (Life Technologies) was
employed to analyze the global expression levels of miRNA associated with the
mitochondria and, separately, the cytosolic fractions. A pre-amplification step using
Megaplex™ PreAmp Primers was added to enhance the detection of low-expression
miRNAs for both mitochondrial and cytosolic fractions. Quantitative PCR was performed
using the ViiA™ 7 Real-Time PCR System (Life Technologies), and the data collected and
processed using ViiA 7 RUO software (Life Technologies). Data that failed QC were
excluded. In addition, individual miRNAs with a cycle threshold (Ct) value of 35 or higher
Exp Neurol. Author manuscript; available in PMC 2016 March 01.
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(Ct>35) were considered as undetectable and excluded from analysis. Using these criteria,
285 out of 381 miRNAs in the Rodent Array Card A were detected in both cytosolic and
mitochondrial fractions (Suppl. File 1). The overall miRNA expression levels in the cytosol
were generally higher relative to mitochondria with an average Ct difference of 1.3, which is
equivalent to a 2.5 fold higher level (Suppl. File 1). The largest differential expression was
observed with rno-miR-333, where expression levels in cytosol were over 100-fold higher
than that found in mitochondria.
Subset of miRNAs is enriched in naïve hippocampal mitochondria

Author Manuscript

Further analysis of the mitochondrial and cytosolic miRNA array data revealed contrasting
miRNA expression pattern in samples from naïve rat hippocampi. While the levels of most
miRNAs were found to be much higher in the cytosol, a subset of miRNAs including mmumiR-741, mmu-miR-142-5p, mmu-miR-302a, mmu-miR-142-3p, rno-miR-339-3p, mmumiR-10a, mmu-miR-146a, mmu-miR-202-3p, mmu-miR-150, mmu-miR-339-5p, and rnomiR-344-5p were found to be at least 1.5 fold higher in mitochondria (Figure 4, Suppl. File
2). Among these mitochondria-enriched miRNAs, miR-142-5p, miR-142-3p, and miR-146a
were significantly higher (p<0.05, FDR < 5%) compared to levels in the cytosol. Although
not statistically significant, miR-150 also displayed enrichment in mitochondria relative to
the cytosol.

Author Manuscript

As a follow-up to the array data described above, TaqMan® single-tube RT-qPCR assays
for miR-142-3p, miR-142-5p, miR-146a, miR-150 were carried out on RNA samples
isolated from mitochondria and cytosol of naïve rat hippocampus (Figure 5A). We also
examined the levels of miR-19b, a miRNA that did not display significantly different levels
between cytosolic and mitochondria fractions, and U6, a small nuclear RNA that does not
associate with mitochondria. The results of the single-tube TaqMan® assays confirmed that
miR-142-3p, miR-142-5p, and miR-146a levels were significantly higher (p<0.05) in
mitochondrial RNA samples relative to the cytosol. As observed in the array data, miR-150
also showed higher trending levels in mitochondria relative to cytosol although not
statistically significant (p=0.11). In comparison, miR-19b levels were not enriched in the
mitochondria, and the small nuclear RNA U6 was approximately 13-fold less abundant in
mitochondria relative to cytosol RNA. We also examined these same miRNAs in
mitochondria and cytosolic fractions isolated from cultured primary rat brain astrocytes. The
TaqMan® assays confirmed that miR-142-3p, miR-142-5p, and miR-146a levels were 2.30,
2.42 and 2.26 fold higher, respectively, in astrocyte mitochondria than that found in cytosol
(Figure 5B).
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Altered expression of hippocampal mitochondria-associated miRNA following severe TBI
TBI resulted in altered expression levels of miRNA in both the hippocampal mitochondria
and cytosol fractions at 12 hr following injury (Suppl. File 1). The TaqMan® RT-qPCR
Array revealed that the differential overall expression levels of miRNAs in cytosol relative
to mitochondria increased from 2.5 fold in naïve samples to 4.2 fold in injured hippocampus
(Suppl. File 1). The levels of most mitochondria-associated miRNAs were decreased at this
early time point following TBI (Table 1, Suppl. Files 1 and 2). In particular, mitochondriaenriched miRNAs such as miR-142-3p, miR-142-5p, and miR-146a were decreased more
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than two fold following TBI, while these miRNAs increased in cytosol. Follow-up singletube TaqMan® assays were used to confirm the initial array data (single-tube assays are
presented in parentheses next to the array data in Table 1). The single-tube assays revealed
that the mitochondria-enriched miRNAs, miR-142-3p and miR-142-5p were indeed
significantly reduced in mitochondrial fractions while levels in cytosol were significantly
increased (see Table 1 for p values). The levels of another mitochondria-enriched miRNA,
miR-146a, were not significantly decreased in mitochondria (p=0.058), but were
significantly higher (p=0.004) in cytosol.
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The levels of several mitochondria-associated miRNAs were found to increase following
TBI. Among them, miR-155 and miR-223 levels were significantly elevated to 7.3 and 4.63
fold higher, respectively, in mitochondria fractions of injured relative to naïve (uninjured)
rats (Table 1). To further validate these changes, single tube TaqMan® RT-qPCR was
carried out for miR-155, miR-223, and a control miRNA, miR-19b, which did not change
after injury. The levels of miR-155 and miR-223 were then normalized against the levels of
miR-19b. RT-qPCR of hippocampal cytosolic and mitochondrial RNA preparations (n = 5
animals in each group) showed that miR-155 and miR-223 were indeed significantly
elevated following TBI (Figure 6), confirming the results of the array experiments. The fold
changes observed in the single-tube RT-qPCR assays were much greater compared to the
array data, which may be due to methodological differences, as well as differences in data
normalization. Notably, in the single-tube RT-qPCR assay, the pre-amplification step was
omitted, and the data normalized using miR-19b.
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MiR-155 and miR-223 are recognized as two hematopoietic cell type specific miRNAs that
are associated with hematopoiesis and leukocyte activation (Fazi et al., 2005; Landgraf et
al., 2007; Rodriguez et al., 2007; Vigorito et al., 2007; Johnnidis et al., 2008). To examine
the possibility that hematopoietic cell infiltration in injured rat hippocampus at 12 hr
following TBI were what caused the miRNA expression we observed in our samples, we
examined CD45 (pan leukocyte cell marker) expression in naïve and TBI hippocampal
cytosolic protein preparations. CD45 levels did not increase in the samples at this early time
point following TBI, indicating that the changes of miR-155 and miR-223 were not
attributable to hematopoietic cell infiltration in response to injury (Suppl. Figure 1).
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We further examined the expression of miRNAs in rat brain cell preparations that were
enriched for particular cell types. TaqMan® miRNA RT-qPCR was used to detect miR-155,
miR-223, miR-146a, miR-142-3p, miR-142-5p, miR-150, and miR-124a expression in
enriched cortical neuron, astrocyte, and microglia cultures. The outcomes of this experiment
demonstrated that miR-155, miR-223, miR-146a, miR-142-3p, miR-142-5p, and miR-150
(data not shown) were detected in all three cell types but showed the highest expression in
microglia and astrocytes (Fig 7), cell types that can mount immune responses. In contrast,
levels of miR-124a were highest in the cortical neuronal cells as expected (Wang et al.,
2008b; Wang et al., 2014).
MiR-155 is known to participate in the regulation of inflammatory responses (KurowskaStolarska et al., 2011; Moore et al., 2013), which also occur at early time points following
TBI. Incubation of rat primary microglia and astrocyte cell cultures with lipopolysaccharide
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(LPS) resulted in strong elevation of miR-155 levels in both cell types (p<0.001 for both
microglia and astrocytes) (Fig 8). These experiments are consistent with prior findings that
miR-155 is responsive to inflammatory mediators, such as LPS, in macrophages, monocytes,
as well as microglia. Unlike miR-155, miR-223 was not elevated in either microglia and
astrocyte cultures treated with LPS, suggesting that up-regulation of these two mRNAs in
hippocampus following TBI may be driven by different signaling events.

Discussion

Author Manuscript

Mitochondria play a critical role in providing cellular energy and respond to a number of
extracellular and intracellular environmental events. However, the signaling events that
regulate miRNA function, especially their potential interactions with cellular organelles are
largely unknown. Emerging research points to a possible interaction between miRNA and
mitochondria (Maniataki and Mourelatos, 2005; Kren et al., 2009; Bian et al., 2010;
Bandiera et al., 2011; Barrey et al., 2011; Huang et al., 2011; Das et al., 2012; ErnoultLange et al., 2012; Latronico and Condorelli, 2012; Sripada et al., 2012), suggesting a
potential novel pathway regulating miRNA function.
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Prior studies have reported detection of miRNAs, ranging from 3 (Mercer et al., 2011) to
428 (Sripada et al., 2012), within or associated with mitochondria from various tissues and
cell types (Lung et al., 2006; Kren et al., 2009; Bian et al., 2010; Bandiera et al., 2011;
Barrey et al., 2011; Huang et al., 2011; Mercer et al., 2011; Das et al., 2012; Sripada et al.,
2012). In the present study, the miRNA TaqMan® qPCR array detected 285 miRNAs in
highly purified naïve hippocampal mitochondria preparations. In addition, although the
average expression level of most of these miRNAs was 2.5-fold lower than the same
miRNA in the cytosol, several miRNAs were preferentially enriched in the mitochondria
preparations. Among them, mitochondria-enriched miR-142-3p, miR-142-5p, miR-146a,
and miR-150 were further validated using RT-qPCR conducted on mitochondrial RNA
isolated from cultured primary rat astrocytes. Previous studies have shown that miR-146a is
enriched in mitochondria from human 143B cells (Mercer et al., 2011) as well as mouse
liver (Bian et al., 2010). Interestingly, all of these mitochondria-associated miRNAs are
known to be involved in immune function and inflammatory responses (Landgraf et al.,
2007; Xiao et al., 2007; Sonkoly et al., 2008; Sun et al., 2010; Vasilatou et al., 2010). Taken
together, these studies suggest the possible existence of a regulatory process by which
certain miRNA or miRNA families are partitioned to mitochondria based on common
functional domains.
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The 12hr post-injury time point we examined corresponds to a dynamic period when
mitochondrial dysfunction, oxidative damage, and cell death are ongoing in the
hippocampus (Baldwin et al., 1997; Lifshitz et al., 2003; Ansari et al., 2008; Davis et al.,
2008; Gilmer et al., 2009). Therefore, it is of interest that mitochondria-associated miRNAs
in the hippocampus displayed significant changes at 12 hr following TBI. Importantly,
mitochondria-enriched miRNAs, such as miR-142-3p, miR-142-5p, and miR-146a were all
decreased at this early time point, while levels of the same miRNA increased in the cytosol.
Any mechanistic explanation for this shift in expression levels at this early time point is
unclear. The ficoll isolation procedure we used captures only intact mitochondria that are at
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different stages of compromised function. Therefore, we believe that the mitochondria to
cytosol shift reflects a true mechanistic event in response to TBI-related cellular stressors. It
is interesting to note that mitochondria in the hippocampus respond to TBI differently than
cortical mitochondria, especially at early time points (Lifshitz et al., 2003; Lifshitz et al.,
2004). In particular, cortical mitochondria are structurally and functionally more
compromised compared to mitochondria from the hippocampus, which is consistent with
differences in cell death responses between these two brain regions (Dietrich et al., 1994;
Hicks et al., 1996; Lifshitz et al., 2003; Lifshitz et al., 2004). It is possible that the structural
and functional changes that occur in the mitochondria are responsible for the observed shift
in miRNA expression patterns. If this indeed is occurring, it will be important to determine
the functional consequences as well as the cell type(s) impacted by this shift in miRNA
expression patterns. This differential temporal and regional response to TBI also guided our
decision to examine changes in mitochondria associated miRNA from the hippocampal
formation at 12 hr following injury. Our observations suggest that mitochondria-associated
miRNAs in the hippocampus are highly sensitive to cellular changes and respond to cellular
stressors by translocating from the mitochondrial to the cytosolic compartment.
Alternatively, these specific miRNAs may be up-regulated in the cytosol after TBI
independent of what is occurring in the mitochondrial compartment. Regardless, the
observation that levels of mitochondria-enriched miRNA decreased after TBI suggests a
potential mechanism by which miRNA function may be regulated in cells under conditions
of duress.
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The levels of miR-155 and miR-223, both of which play a role in several biological/
pathological processes including immunity, cancer, and inflammatory responses (Sonkoly et
al., 2008; Quinn and O’Neill, 2011; Higgs and Slack, 2013; Vigorito et al., 2013; Seddiki et
al., 2014; Taibi et al., 2014), were significantly elevated in both the mitochondria as well as
cytosolic fractions. MiR-223 levels have previously been shown to be elevated in rat total
hippocampal tissue, or cerebral cortex homogenates at different times following TBI (Lei et
al., 2009; Redell et al., 2009). Interestingly, miR-155 levels were found to increase in
mitochondria isolated from mouse liver after streptozotocin treatment, which is known to
produce Type 1 diabetes in animal model and impair mitochondria function (Bian et al.,
2010). We further tested the potential signaling pathways that trigger elevated miR-155 and
miR-223 by treating primary astrocyte and microglia cells with LPS, which activates the
Toll-like receptor signaling pathway leading to an inflammatory response (Hoshino et al.,
1999). The results of this experiment demonstrated that miR-155, but not miR-223, was
significantly up-regulated in both astrocyte and microglia following LPS treatment. One
explanation for this differential effect of LPS is that the up-regulation of miR-155 and
miR-223 in the hippocampus following TBI may be driven by different injury-related
signaling events.
Recent studies have reported changes in several miRNAs in the hippocampus following TBI
(Lei et al., 2009; Redell et al., 2009; Redell et al., 2010; Truettner et al., 2011; Hu et al.,
2012; Truettner et al., 2013; Liu et al., 2014; Sabirzhanov et al., 2014; Sun et al., 2014). The
results of our experiments revealed an increase in miR-223 in both mitochondria and
cytosol, which is consistent with the results of previous studies using the same injury model
and whole tissue homogenates (Lei et al., 2009; Redell et al., 2009) However, we did not
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detect significant changes in levels of several other miRNAs, (such as miR-107 and miR-21)
that have been reported to respond to TBI. It is difficult to compare the results of the present
study examining changes in mitochondrial versus cytoplasmic miRNA levels with existing
studies that examined miRNA changes in whole tissue homogenates. In addition, we chose
the 12hr post-injury recovery period as it captures an early time point when there is a
maximal loss of bioenergetics and structural integrity in hippocampal mitochondria
following the injury (Lifshitz et al., 2003; Singh et al., 2006; Gilmer et al., 2009). Finally,
differences in the injury model and the miRNA assay systems used may contribute to some
of the variations in the results observed across studies. Therefore, it will be important to
examine changes in mitochondrial and cytosolic miRNA expression patterns at other time
points using the same injury model and miRNA detection system.
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TBI induces secondary signaling events that are biochemically relevant to functional
recovery (McIntosh et al., 1998; Rosenfeld et al., 2012). Overall, the results of our study
suggest that mitochondria-associated miRNAs actively participate in the response to TBI.
However, the events contributing to mitochondria and miRNA interactions, and the
mechanism(s) affecting altered mitochondria-associated miRNA levels following TBI are
still largely unknown. A previous study has demonstrated a dynamic interaction between
mitochondria and miRNA associated processing bodies (P-bodies) (Huang et al., 2011).
Interestingly, this same study reported that treatment of mitochondria with an uncoupling
agent resulted in delocalization of AGO from P-bodies, which led to a significant decrease
in miRNA mediated RNAi efficiency. Although additional studies are required to reveal the
crosstalk and trafficking of miRNAs between mitochondria, cytosol, and other cellular
organelles/compartments, this study raises the possibility that mitochondria play a role in
regulating miRNA function. Future studies exploring this dynamic interaction, and its
implication in various pathophysiological processes may lead to a better understanding of
secondary damage following TBI.
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Highlights
MiRNA machinery proteins Argonaute and Dicer are present in hippocampal
mitochondria
Several miRNAs are enriched in hippocampal mitochondria under normal conditions
Numerous mitochondria-associated miRNAs are significantly altered following TBI
MiRNAs enriched in mitochondria decreased and cytosolic levels increased after
TBI
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Figure 1. Purity of isolated mitochondria
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Western blot analysis and RT-qPCR were used to examine the purity of isolated
mitochondria. The results suggested that the mitochondria preparations were relatively free
from cytosolic or nuclear contaminations. A. Rat hippocampal cytosolic, mitochondrial, and
nuclear proteins were subjected to Western blot analysis using β-tubulin (cytosol marker),
PDH (mitochondria marker), and Histone H3 (nuclear marker) antibodies. 1: Total brain
homogenate; 2: Total hippocampal homogenate; 3: Cytosolic fraction; 4: Nuclear fraction; 5
and 7: Blank; 6: Mitochondrial fraction with 2X ficoll gradient; 8: Mitochondrial fraction
with 1X Ficoll gradient. B. TaqMan® RT-qPCR for GAPDH in cytosol and mitochondria
preparations. Cyto: cytosol; Mito: mitochondria.
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Figure 2. MiRNA machinery proteins Dicer and AGO2 were present in rat brain mitochondria
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Isolated mitochondria and mitochondrial subfractions were analyzed for Dicer and AGO2
using Western blotting. Antibodies against marker proteins for the mitochondria
subfractions included VDAC (outer membrane), CoxIV (inner membrane), and PDH
(matrix). Brain Homog.: total brain homogenate; Total MT: total mitochondria lysate; MS:
mitochondrial supernatant containing broken outer membrane and inter-membrane space
compartments; OM: outer membrane; IMS: inter-membrane space; MP: mitoplast; IM: inner
membrane; MTX: mitochondria matrix.
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Figure 3. Enrichment of mitochondrial miRNA in AGO complexes

Co-immunoprecipitation (co-IP) with anti-AGO 2A8 antibody was performed using isolated
total mitochondrial lysate. Corresponding cytosols were also subjected to co-IP. The co-IP
RNAs were extracted and analyzed using RT-qPCR TaqMan® assays for miR-23a,
miR-107, and miR-124a, and a control small nuclear RNA U6. MiRNAs were specifically
enriched in anti-AGO 2A8 antibody co-immunoprecipitates (IP2A8), while co-IP using
normal mouse serum (IPNMS, data not shown) did not result in any specific signal. As
expected, U6, which does not associate with AGO complexes was not detected in co-IP
RNA samples. Inset: Western blot analysis of the IP products using anti-AGO 2A8 antibody
(IP2A8) or normal mouse serum (IPNMS). TL: total lysate.

Author Manuscript
Author Manuscript
Exp Neurol. Author manuscript; available in PMC 2016 March 01.

Wang et al.

Page 22

Author Manuscript
Author Manuscript

Figure 4. Differential miRNA enrichment in cytosol and mitochondria
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Volcano plot of RT-qPCR array data displayed differential miRNA enrichment in cytosol
and mitochondria. Each data point was plotted as the level of fold change
(Log2(Fold Change—Mito vs Cyto)) on the X-axis and corresponding statistical level of
significance (−log10(p value)) on the y-axis. Fold change=2^ −(CtMito − CtCyto). Mitochondriaenriched miRNAs with a more than 2 fold change were colored in red; likewise, cytosolenriched miRNAs that having a change more than 2 fold were colored in green. Data points
above the red-dashed-line are statistically significant (p < 0.05). The numeric data set of this
plot is provided in Suppl. File 2.
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Figure 5. Subset of miRNAs was enriched in mitochondria
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Single-tube TaqMan® assays further validated that a subset of miRNAs was enriched in
mitochondria. TaqMan® assays for the indicated miRNAs and U6 were performed using rat
hippocampal mitochondrial (Mito) and cytosolic (Cyto) preparations (A), or rat cortical
astrocyte mitochondrial and cytosolic preparations (B). The results demonstrated that
miR-142-3p, miR-142-5p, and miR-146a are enriched in mitochondrial fractions, which is
consistent with the array findings.
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Figure 6. MiR-155 and miR-223 were highly elevated following TBI

Single-tube TaqMan® assays for miR-155 and miR-223 using mitochondrial (Mito) and
cytosolic (Cyto) preparations from TBI and naïve rat hippocampi demonstrated a strong
induction of these two miRNAs following TBI in both mitochondrial and cytosolic fractions.
Fold change was calculated relative to the levels observed in naïve samples.
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Figure 7. MiR-155, miR-223, miR-146a, miR-142-3p, miR-142-5p, and miR-150 are detected in
rat brain cells
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TaqMan® assays for miR-155, miR-223, miR-146a, miR-142-3p, miR-142-5p, and
miR-150 (not shown) were performed using total RNAs isolated from untreated primary
cortical neuron, astrocyte, and microglia enriched cultures. These miRNAs were readily
detected in all three primary cell types with high expression levels in the astrocyte and
microglial cells. As a control, a neuronal enriched miRNA, miR-124a, was tested in parallel.
Expression levels of miRNAs are presented as fold change relative to levels in primary
cortical neurons. The one exception is miR-124a, the levels of which are expressed relative
to levels in primary astrocytes. Average Ct values of neuronal RNA samples were 28.2,
26.6, 28.0, 23.9, 28.9, 23.1, and 19.1 for miR-155, miR-223, miR-150, miR-146a,
miR-142-3p, miR-142-5p, and miR-124a, respectively.
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Figure 8. MiR-155 responds to LPS treatments in rat astrocyte and microglia
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TaqMan® assays for miR-155 (A) and miR-223 (B). There was a significant elevation of
miR-155, but not miR-223, in response to LPS treatment in both astrocyte and microglia cell
cultures; These results suggest that the up-regulation of miR-155 and miR-223 in
hippocampus following TBI may be driven by different signaling pathways. C. Western blot
analysis showed that iNOS was induced in response to LPS treatment in primary microglial
cell cultures. Fold change was calculated relative to the levels detected in untreated control
cells.
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Changes in mitochondria-associated and cytosolic miRNAs at 12 hr following TBI
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List of miRNAs with significant changes based on the RT-qPCR array analysis. Data and p values presented
in parentheses were follow-up studies using single-tube TaqMan assay analysis. Red and green colors
designate miRNA that significantly increased or decreased, respectively, in each fraction. Fold difference of
each miRNA was calculated following the formula: Fold Change=2^ −(CtTBI − CtNaive). Permutation test was
used to control False Discovery Rate (FDR). All significant data point (p<0.05) has a FDR< 5%.
Mitochondria
miRNA

Cytosol
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Fold Change (TBI vs Naïve)

P Value

Fold Change (TBI vs Naïve)

P Value

mmu-miR-155

7.30

0.023

5.2

0.05

mmu-miR-223

4.63

0.021

14.9

3.2E-06

mmu-miR-15a

0.66

0.043

1.06

0.885

rno-miR-421

0.65

0.048

1.13

0.705

mmu-miR-532-3p

0.56

0.014

1.05

0.881

rno-miR-532-5p

0.56

0.019

1.11

0.646

mmu-miR-344

0.54

0.045

0.97

0.885

mmu-miR-187

0.52

0.0008

0.76

0.140

mmu-miR-434-5p

0.52

0.038

0.90

0.727

mmu-miR-142-5p

0.28 (0.5)

0.031 (0.004)

2.02 (1.95)

0.168 (0.022)

mmu-miR-1

0.23

0.017

0.63

0.458

mmu-miR-10a

0.17

0.033

1.39

0.767

mmu-miR-743a

Author Manuscript

0.06

0.009

2.30

0.552

mmu-miR-142-3p

0.47 (0.49)

0.176 (0.0004)

2.15 (1.73)

0.112 (0.008)

mmu-miR-292-3p

5.18

0.140

8.61

0.074

rno-miR-224

1.87

0.571

5.11

0.058

mmu-miR-224

1.67

0.621

3.77

0.015

mmu-miR-200c

0.82

0.694

1.67

0.068

mmu-miR-682

2.33

0.245

1.55

0.024

mmu-miR-146a

0.44 (0.61)

0.134 (0.058)

1.47 (1.40)

0.251 (0.004)
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